Clinical data from the SURMOUNT-1 trial highlights tirzepatides ability to achieve 20.9% body weight reduction, while STEP 1 trials confirm semaglutides reliable 14.9% average loss
Additionally, GLP-1RA is associated with gastrointestinal adverse events, which may cause absorption of minerals and nutrients and thereby interfere with the beneficial function of GLP-1RA on bone physiology (22)
General Chapter 797: Pharmaceutical Compounding - Sterile Preparations
Petrolatum, Caprylic/Capric Triglyceride, Isoamyl Laurate, Hydrogenated Vegetable Oil, Cocoa Butter, Macadamia Seed Oil, Cetearyl Ethylhexanoate, Hydrogenated Polyisobutene, Diisostearyl Malate, Cetearyl Alcohol, Tocopheryl Acetate (500 Ppm), Purified Water, Ascorbic Acid (1 Ppm), 1,2-Hexanediol, Caprylyl Glycol, Glycerin, Glyceryl Caprate, Fragrance, Alpha-Isomethyl Ionone, Citral, Limonene, Linalool